Ironwood Pharmaceuticals, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US46333X1081
USD
4.45
3.86 (659.26%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
122.06
85.24
41.14
90.55
91.59
94.40
74.88
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
122.06
85.24
41.14
90.55
91.59
94.40
74.88
Raw Material Cost
0.47
0.47
0.48
0.48
0.51
0.51
0.51
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
8.43
8.36
8.07
8.91
9.42
7.47
7.23
Selling and Distribution Expenses
21.91
16.80
24.26
33.33
27.61
36.96
37.60
Other Expenses
1.36
1.45
1.89
1.45
1.99
2.24
1.81
Total Expenditure (Excl Depreciation)
44.38
40.17
51.69
57.26
57.44
67.35
63.42
Operating Profit (PBDIT) excl Other Income
77.69999999999999
45.099999999999994
-10.5
33.3
34.2
27
11.5
Other Income
0.97
0.86
0.91
0.78
1.15
1.37
1.17
Operating Profit (PBDIT)
79.13
46.39
-9.16
34.55
35.81
28.92
13.14
Interest
8.43
8.36
8.07
8.91
9.42
7.47
7.23
Exceptional Items
-2.20
0.25
-18.56
-0.07
-8.52
-2.07
-0.44
Gross Profit (PBDT)
121.58
84.77
40.66
90.06
91.08
93.89
74.36
Depreciation
0.47
0.47
0.48
0.48
0.51
0.51
0.51
Profit Before Tax
68.02
37.82
-36.27
25.08
17.37
18.88
4.96
Tax
27.94
14.22
1.11
21.89
13.72
19.74
9.12
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
40.08
23.60
-37.39
3.19
3.65
-0.86
-4.16
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
40.08
23.60
-37.39
3.19
3.65
-0.86
-4.16
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
40.08
23.60
-37.39
3.19
3.65
-0.86
-4.16
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
-264.16
-308.16
-334.05
-301.33
-311.33
-321.73
-330.52
Earnings per share (EPS)
0.23
0.14
-0.23
0.02
0.02
-0.01
-0.03
Diluted Earnings per share
0.23
0.14
-0.23
0.02
0.02
-0.01
-0.03
Operating Profit Margin (Excl OI)
63.64%
52.88%
-25.64%
36.77%
37.29%
28.65%
15.3%
Gross Profit Margin
56.12%
44.92%
-87.0%
28.23%
19.52%
20.53%
7.31%
PAT Margin
32.84%
27.69%
-90.87%
3.52%
3.98%
-0.91%
-5.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 43.31% vs 107.30% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 69.92% vs 163.10% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 71.87% vs 550.50% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 0.00% vs 3.70% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Ironwood Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
122.06
192.10
-70.04
-36.46%
Other Operating Income
0.00
0.00
0.00
Total Operating income
122.06
192.10
-70.04
-36.46%
Raw Material Cost
0.47
43.79
-43.32
-98.93%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
8.43
0.00
8.43
Selling and Distribution Expenses
21.91
180.48
-158.57
-87.86%
Other Expenses
1.36
2.89
-1.53
-52.94%
Total Expenditure (Excl Depreciation)
44.38
253.13
-208.75
-82.47%
Operating Profit (PBDIT) excl Other Income
77.68
-61.03
138.71
227.28%
Other Income
0.97
2.28
-1.31
-57.46%
Operating Profit (PBDIT)
79.13
-33.93
113.06
333.22%
Interest
8.43
0.00
8.43
Exceptional Items
-2.20
0.80
-3.00
-375.00%
Gross Profit (PBDT)
121.58
148.31
-26.73
-18.02%
Depreciation
0.47
24.82
-24.35
-98.11%
Profit Before Tax
68.02
-57.95
125.97
217.38%
Tax
27.94
-12.84
40.78
317.60%
Provisions and contingencies
0
0
0.00
Profit After Tax
40.08
-45.12
85.20
188.83%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
40.08
-45.12
85.20
188.83%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
40.08
-45.12
85.20
188.83%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
-264.16
1,049.67
-1,313.83
-125.17%
Earnings per share (EPS)
0.23
-0.80
1.03
128.75%
Diluted Earnings per share
0.23
-0.80
1.03
128.75%
Operating Profit Margin (Excl OI)
63.64%
-31.77%
0.00
95.41%
Gross Profit Margin
56.12%
-17.25%
0.00
73.37%
PAT Margin
32.84%
-23.49%
0.00
56.33%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 12.21 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 43.31% vs 107.30% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 33.30% vs -19.44% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.01 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 69.92% vs 163.10% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 1,013.89% vs -74.29% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.82 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 71.87% vs 550.50% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 125.36% vs -29.33% in Sep 2024

Quarterly - Interest
Interest 0.84 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 0.00% vs 3.70% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -10.64% vs -4.08% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 63.64%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024